To investigate this question, we crossed dysferlin-deficient mice with two distinct dystroglycanopathy mouse models and analyzed the resultant phenotypes. Here, DYSF is linked to neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan.